Regulators of G protein Signaling (RGS) proteins (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database by Alqinyah, Mohammed et al.
IUPHAR/BPS Guide to Pharmacology CITE
https://doi.org/10.2218/gtopdb/F891/2019.4
Regulators of G protein Signaling (RGS) proteins (version 2019.4) in
the IUPHAR/BPS Guide to Pharmacology Database
Mohammed Alqinyah1, Christopher Bodle2, Josephine Bou Dagher1, Bandana Chakravarti2, Shreoshi P.
Choudhuri3, Kirk M. Druey4, Rory A. Fisher2, Kyle J. Gerber5, John R. Hepler5, Shelley B. Hooks1, Havish S.
Kantheti3, Behirda Karaj6, Jae-Kyung Lee1, Zili Luo2, Kirill Martemyanov7, Luke D. Mascarenhas3, Hoa Phan Thi
Nhu6, David L. Roman2, Vincent Shaw6, Benita Sjögren8, Katherine E. Squires5, Laurie Sutton7, Thomas M.
Wilkie3, Keqiang Xie7 and Yalda Zolghadri3
1. University of Georgia, USA
2. University of Iowa, USA
3. University of Texas Southwestern Medical Center, USA
4. National Institutes of Health, USA
5. Emory University, USA
6. Michigan State University, USA
7. Scripps Research Institute, USA
8. Purdue University, USA
Abstract
Regulators of G protein signalling (RGS) proteins display a common RGS domain that interacts with the GTP-
bound Gα subunits of heterotrimeric G proteins, enhancing GTP hydrolysis by stabilising the transition state [29,
419, 418], leading to a termination of GPCR signalling. Interactions through protein:protein interactions of many
RGS proteins have been identified for targets other than heteromeric G proteins. Sequence analysis of the 20
RGS proteins suggests four families of RGS: RZ, R4, R7 and R12 families. Many of these proteins have been
identified to have effects other than through targetting G proteins. Included here is RGS4 for which a number of
pharmacological inhibitors have been described.
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This is a citation summary for Regulators of G protein Signaling (RGS) proteins in the Guide to Pharmacology
database (GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and
from the database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the
database which are given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
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Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
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